Guo, Shuling <br/><br/>
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.  [electronic resource] 

 -  Rare diseases (Austin, Tex.)  2014 
 - e28511 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2167-5511 
<br/><br/><label>Standard No.: </label>10.4161/rdis.28511  doi